Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 15/09/2009
PIL Cardura

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/09/2009 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 10/08/2009 and displayed until 15/09/2009
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
Updated on 01/08/2008 and displayed until 10/08/2009
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 22/05/2008 and displayed until 01/08/2008
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 29/11/2007 and displayed until 22/05/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 23/08/2007 and displayed until 29/11/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 13/11/2006 and displayed until 23/08/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change from BAN to rINN
Updated on 06/01/2006 and displayed until 13/11/2006
Reasons for adding or updating:
  • Change of manufacturer
  • Change of licence holder
  • Change to date of revision
Updated on 04/12/2003 and displayed until 06/01/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 19/11/2003 and displayed until 04/12/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 13/09/2000 and displayed until 19/11/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   doxazosin mesilate